Haplotypes in the<i>CRP</i>Gene Associated with Increased BMI and Levels of CRP in Subjects with Type 2 Diabetes or Obesity from Southwestern Mexico

América Martínez-Calleja, Irma Quiróz-Vargas, Isela Parra‐Rojas, José Francisco Muñóz-Valle, Marco Antonio Leyva‐Vázquez, Gloria Fernández‐Tilapa, Amalia Vences-Velázquez, Miguel Cruz, Eduardo Salazar-Martı́nez, Eugenia Flores‐Alfaro

Experimental Diabetes Research · 2012 · 22 citations · 29 references

DOIFull text

Open access

Concepts

Abstract

OBJECTIVE: We evaluated the association between four polymorphisms in the CRP gene with circulating levels of C-reactive protein (CRP), type 2 diabetes (T2D), obesity, and risk score of coronary heart disease. METHODS: We studied 402 individuals and classified them into four groups: healthy, obese, T2D obese, and T2D without obesity, from Guerrero, Southwestern Mexico. Blood levels of CRP, glucose, cholesterol, triglycerides, and leukocytes were measured. Genotyping was performed by PCR/RFLP, and the risk score for coronary heart disease was determined by the Framingham's methodology. RESULTS: The TT genotype of SNP rs1130864 was associated with increased body mass index and T2D patients with obesity. We found that the haplotype 2 (TGAG) was associated with increased levels of CRP (β = 0.3; 95%CI: 0.1, 0.5; P = 0.005) and haplotype 7 (TGGG) with higher body mass index (BMI) (β = 0.2; 95%CI: 0.1, 0.3; P < 0.001). The risk score for coronary heart disease was associated with increased levels of CRP, but not with any polymorphism or haplotype. CONCLUSIONS: The association between the TT genotype of SNP rs1130864 with obesity and the haplotype 7 with BMI may explain how obesity and genetic predisposition increase the risk of diseases such as T2D in the population of Southwestern Mexico.

References

29